In cardiovascular disease models, both NEU1 and NEU3 are upregulated, and genetic disruption of NEU1 or NEU3 in mice, or treatment of mice with sialidase inhibitors, attenuate atherosclerosis, cardiac hypertrophy, or cardiac fibrosis [48,49,50]. This evidence concerns the gene NEU3 and atherosclerosis.